Skip to main content
. 2016 Jun 7;64(7):441–453. doi: 10.1369/0022155416652611

Table 1.

Summary of the Roles of Periostin in Bleomycin-Induced Lung Injury From the Three Reports.

Strain Intratracheal Administrated Bleomycin (Equivalent Unit, Supplier) Survival Rate Cause of Death Role of Periostin
Uchida et al.6 BALB/c; WT (n=7) vs. KO (n=16) 10 mg/kg (10 U/kg; Nippon Kayaku) Less than 20% in WT; about 90% in KO (day 28) Pulmonary fibrosis Induction of inflammation
Naik et al.8 C57BL/6; periostin-neutralizing antibody (injected 10 and 15 days after bleomycin administration, n=10 each) 0.05 unit per mouse (about 2 U/kg; Sigma) 40% in control antibody; 100% in neutralizing antibody (day 19) Pulmonary fibrosis Fibrosis progression
This study C57BL/6; WT (n=17) vs. KO (n=31) 2.5 U/kg (LKT Laboratories) About 90% in WT; about 55% in KO (day 21) Alveolar rupture Increase in ECM stability

WT and KO indicate the wild-type mice and the periostin-null mice, respectively. Abbreviation: ECM, extracellular matrix.